GSK Spin-Out NeRRe Raises £23m For NK Antagonists
New cash will fund further clinical testing of NeRRe's two neurokinin receptor antagonists for cough and hot flashes.
New cash will fund further clinical testing of NeRRe's two neurokinin receptor antagonists for cough and hot flashes.